Insider Transactions in Q2 2025 at Crinetics Pharmaceuticals, Inc. (CRNX)

CRNX Quotes by TradingView

Insider Transaction List (Q2 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Apr 02 2025
Richard Scott Struthers President & CEO
BUY
Exercise of conversion of derivative security
Direct
81,270 +16.53%
$81,270 $1.91 P/Share

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRNX